These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 36465073)

  • 1. Regulation of cGAS-STING Pathway - Implications for Systemic Lupus Erythematosus.
    Hagiwara AM; Moore RE; Wallace DJ; Ishimori M; Jefferies CA
    Rheumatol Immunol Res; 2021 Sep; 2(3):173-184. PubMed ID: 36465073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. cGAS-STING pathway in systemic lupus erythematosus: biological implications and therapeutic opportunities.
    Feng Q; Xu X; Zhang S
    Immunol Res; 2024 Aug; ():. PubMed ID: 39096420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclic guanosine monophosphate-adenosine monophosphate synthetase/stimulator of interferon genes signaling aggravated corneal allograft rejection through neutrophil extracellular traps.
    Wei C; Huang Q; Zeng F; Ma L; Bai X; Zhu X; Gao H; Qi X
    Am J Transplant; 2024 Sep; 24(9):1583-1596. PubMed ID: 38648890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations in the non-catalytic polyproline motif destabilize TREX1 and amplify cGAS-STING signaling.
    Shim A; Luan X; Zhou W; Crow Y; Maciejowski J
    bioRxiv; 2024 Jan; ():. PubMed ID: 38260344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutations in the non-catalytic polyproline motif destabilize TREX1 and amplify cGAS-STING signaling.
    Shim A; Luan X; Zhou W; Crow YJ; Maciejowski J
    Hum Mol Genet; 2024 Sep; 33(18):1555-1566. PubMed ID: 38796715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondrial DNA Programs Lactylation of cGAS to Induce IFN Responses in Patients with Systemic Lupus Erythematosus.
    Zhang J; Ji H; Liu M; Zheng M; Wen Z; Shen H
    J Immunol; 2024 Sep; 213(6):795-807. PubMed ID: 39093026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulating STING in health and disease.
    Li Y; Wilson HL; Kiss-Toth E
    J Inflamm (Lond); 2017; 14():11. PubMed ID: 28596706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanoformulations of chemotherapeutic activators of the cGAS-STING pathway in tumor chemoimmunotherapy.
    Wang L; Yu Z; Zhang J; Guo J
    Drug Discov Today; 2024 Mar; 29(3):103892. PubMed ID: 38272174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferonopathies: From concept to clinical practice.
    Mendonça LO; Frémond ML
    Best Pract Res Clin Rheumatol; 2024 Sep; 38(3):101975. PubMed ID: 39122631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Double-filtration plasmapheresis reduces type I interferon bioavailability and inducing activity in systemic lupus erythematosus.
    Saito T; Takatsuji R; Murayama G; Yamaji Y; Hagiwara Y; Nishioka Y; Kuga T; Miyashita T; Kusaoi M; Tamura N; Yamaji K
    Immunol Med; 2024 Jul; ():1-11. PubMed ID: 38952099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelial type I interferon response and brain diseases: identifying STING as a therapeutic target.
    Duarte N; Shafi AM; Penha-Gonçalves C; Pais TF
    Front Cell Dev Biol; 2023; 11():1249235. PubMed ID: 37791071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitors of Stimulator of Interferon Genes from 2019 to July 2022: An Overview of the Structure and Bioactivity.
    Xu F; Tian X; Zhu Q; Feng Z; Li H; Dai W; Zhou Y; You QD; Xu X
    Curr Drug Targets; 2023; 24(12):959-980. PubMed ID: 37653633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitochondrial DNA Sensing Pathogen Recognition Receptors in Systemic Sclerosis Associated Interstitial Lung Disease: A Review.
    Ghincea A; Woo S; Yu S; Pivarnik T; Fiorini V; Herzog EL; Ryu C
    Curr Treatm Opt Rheumatol; 2023 Dec; 9(4):204-220. PubMed ID: 38230363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Type I interferon-mediated monogenic autoinflammation: The type I interferonopathies, a conceptual overview.
    Rodero MP; Crow YJ
    J Exp Med; 2016 Nov; 213(12):2527-2538. PubMed ID: 27821552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenetics of the Ocular Anterior Segment: Lessons from Inherited Disorders.
    Serpen JY; Armenti ST; Prasov L
    J Ophthalmol; 2021; 2021():6691291. PubMed ID: 34258050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nucleic acid sensor STING drives remodeling and its inhibition enhances steroid responsiveness in chronic obstructive pulmonary disease.
    Mdkhana B; Saheb Sharif-Askari N; Ramakrishnan RK; Al-Sheakly BK; Hafezi S; Saheb Sharif-Askari F; Bajbouj K; Hamid Q; Halwani R
    PLoS One; 2023; 18(7):e0284061. PubMed ID: 37406004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of the cGAS-STING innate immune response in cells with deficient mitochondrial topoisomerase TOP1MT.
    Al Khatib I; Deng J; Lei Y; Torres-Odio S; Rojas GR; Newman LE; Chung BK; Symes A; Zhang H; Huang SN; Pommier Y; Khan A; Shadel GS; West AP; Gibson WT; Shutt TE
    Hum Mol Genet; 2023 Jul; 32(15):2422-2440. PubMed ID: 37129502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of adenosine A2a receptor in cancers and autoimmune diseases.
    Ye H; Zhao J; Xu X; Zhang D; Shen H; Wang S
    Immun Inflamm Dis; 2023 Apr; 11(4):e826. PubMed ID: 37102661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic lupus erythematosus: presence in human serum of an unusual acid-labile leukocyte interferon.
    Preble OT; Black RJ; Friedman RM; Klippel JH; Vilcek J
    Science; 1982 Apr; 216(4544):429-31. PubMed ID: 6176024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune interferon in the circulation of patients with autoimmune disease.
    Hooks JJ; Moutsopoulos HM; Geis SA; Stahl NI; Decker JL; Notkins AL
    N Engl J Med; 1979 Jul; 301(1):5-8. PubMed ID: 449915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.